<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Post-therapy neuronal maturation in adult medulloblastoma: a case report with literature integration

dc.contributor.authorYavuz, Mert
dc.contributor.authorAlioglu, Halit
dc.contributor.authorOsama, Mahmoud
dc.contributor.authorCiftci, Tufan
dc.contributor.authorAydin, Serdar Onur
dc.date.accessioned2026-11-05T11:03:42Z
dc.date.issued2026
dc.description.abstractIntroduction Post-therapy neuronal maturation (PTNM) is a rare phenomenon in medulloblastoma, in which a tumor that initially exhibits embryonal morphology acquires differentiated neuronal features after multimodal treatment. While several pediatric cases have been documented, reports in adults remain exceptional. Case presentation We describe a 21-year-old woman who presented with headache, dizziness, and gait unsteadiness. MRI demonstrated a right cerebellar mass, and gross total resection revealed desmoplastic/nodular medulloblastoma (WHO grade 4) with high proliferative activity (Ki-67 similar to 45% in internodular areas). She subsequently underwent craniospinal irradiation with a posterior fossa boost and multi-agent chemotherapy. Fourteen months later, surveillance MRI identified a recurrent posterior fossa lesion. Repeat resection showed a hypocellular nodular architecture within gliotic stroma, with diffuse synaptophysin and NeuN expression, strong neurofilament reactivity, partial GFAP positivity, and a markedly reduced Ki-67 index (1-2%). These findings were consistent with therapy-related neuronal maturation rather than true recurrence. No further adjuvant therapy was administered, and the patient remains alive and disease-free 40 months after initial diagnosis. Conclusions This case provides additional evidence that post-therapy neuronal maturation can occur in adult medulloblastoma and may dominate the histological picture at recurrence. Accurate recognition of this endpoint preserves diagnostic continuity, prevents misclassification as a glioneuronal tumor, and emphasizes the need for larger adult series to clarify its prognostic significance and implications for long-term management.
dc.description.pages106017
dc.description.volume6
dc.identifier.doi10.1016/j.bas.2026.106017
dc.identifier.issn2772-5294
dc.identifier.urihttps://doi.org/10.1016/j.bas.2026.106017
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/11095
dc.identifier.wosWOS:001730891600001
dc.language.isoen
dc.publisherELSEVIER
dc.relation.hasversion10.1016/j.bas.2026.106017
dc.relation.ispartofBRAIN AND SPINE
dc.subjectMedulloblastoma
dc.subjectPost-therapy neuronal maturation
dc.subjectAdult brain tumors
dc.subjectImmunohistochemistry
dc.subjectHistologic differentiation
dc.subjectChemoradiotherapy
dc.subjectCENTRAL-NERVOUS-SYSTEM
dc.subjectCLASSIFICATION
dc.subjectTUMORS
dc.subjectDIFFERENTIATION
dc.subjectGANGLIOCYTOMA
dc.subjectClinical Neurology
dc.subjectNeurosciences & Neurology
dc.titlePost-therapy neuronal maturation in adult medulloblastoma: a case report with literature integration
dc.typeArticle
oaire.citation.editionEmerging Sources Citation Index (ESCI)
oaire.citation.volume6
person.identifier.ridAFQ-5712-2022

Files

Collections